Abstract:Background Cervical cancer patients have a high risk of metastasis and a poor prognosis with shorter disease-free survival. Thus, novel biomarkers and feasible therapies urgently need to be discovered. Previous studies have shown that miR-95-3p plays crucial roles in several cancer types. However, the roles of miR-95-3p in cervical cancer remain unknown. Methods The micro ribonucleic acid (miRNA) expression data and clinical characteristics of cervical cancer samples were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analyses were conducted to identify the prognostic-related miRNAs. The potential target genes of miR-95-3p were predicted by the TargetScan database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted to explore the target gene of miR-95-3p. The effects of miR-95-3p inhibition and overexpression on cell proliferation were inspected by cell counting kit-8 (CCK-8) assays and cell colony formation assays. Wound-healing assays and transwell assays were also used to examine cell migration ability in HeLa and SiHa cells. Results MiR-95-3p was the only miRNA significantly associated with the poor prognosis of cervical squamous cell carcinoma. A further analysis suggested that vascular cell adhesion molecule 1 (VCAM1) is a target gene of miR-95-3p in cervical cancer, and miR-95-3p promotes the malignant behavior of cervical cancer cells by inhibiting the expression of VCAM1. The CCK-8 and cell colony assays showed that miR-95-3p downregulation significantly suppressed cell proliferation in the HeLa and SiHa cells. The transwell and wound-healing assays showed that miR-95-3p inhibition suppressed cell migration in the HeLa and SiHa cells. Further the Western blot analysis and the quantitative real-time-polymerase chain reaction (qRT-PCR) showed that the knockdown of miR-95-3p in HeLa cells resulted in increased VCAM1 expression. And VCAM1 was highly expressed in the paired adjacent normal cervical epithelium tissue samples, but lowly expressed in the cervical tumor tissue samples. Conclusions Our study was the first to show that miR-95-3p could serve as a prognostic biomarker of cervical cancer. Mechanistically, we discovered that miR-95-3p inhibited the expression of the cell adhesion molecule VCAM1 and thus promoted further tumor progression.

Vitamin D-Regulated miR-589-3p in Patients with Cervical Cancer Predicts Patient Prognosis and is Involved in Tumor Progression

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis

MiR-95-3p Acts As a Prognostic Marker and Promotes Cervical Cancer Progression by Targeting VCAM1

Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer

Association Of Microrna-181c Expression With The Progression And Prognosis Of Human Gastric Carcinoma

Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis

MicroRNA-889-3p Targets FGFR2 to Inhibit Cervical Cancer Cell Viability and Invasion.

Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach

Circulating Mir-449A Predicts Survival Outcome for Colorectal Cancer Following Curative Resection: an Observational Study.

Downregulation of Mir-193A-5p Correlates with Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer

Micro RNA (mir)‐203 and Mir‐205 Expression Patterns Identify Subgroups of Prognosis in Cutaneous Squamous Cell Carcinoma

[Relationships Between Microrna Expressions and Prognosis in Patients with Tongue Squamous Cell Carcinoma and the Mechanisms Microrna Regulating Tongue Squamous Cell Carcinoma Biological Behavior].

MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma

Bioinformatics analysis illustrates the functions of miR-377-5p in cervical cancer

The Impact of Pri-Mir-218 Rs11134527 on the Risk and Prognosis of Patients with Esophageal Squamous Cell Carcinoma.

Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively

The Expression Level of Mir-203 in Patients with Gastric Cancer and Its Clinical Significance.